Semin Thromb Hemost 2011; 37(5): 431-439
DOI: 10.1055/s-0031-1281035
EDITORIAL

© Thieme Medical Publishers

2011 Eberhard F. Mammen Award Announcements

Emmanuel J. Favaloro1
  • 1Department of Haematology, ICPMR, Westmead Hospital, Westmead, NSW Australia
Further Information

Publication History

Publication Date:
18 November 2011 (online)

As we have mentioned on several occasions,[1] [2] [3] Thieme, the publisher of Seminars in Thrombosis and Hemostasis, recently created the Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards in honor of Eberhard F. Mammen (Fig. [1]), and in recognition of his contribution to this field and to the journal that he both founded and steered for over three decades. These awards began in 2009, under two categories:

Figure 1 Dr. Eberhard F Mammen (1930–2008).

Most popular article awards: Awarded to the authors of the most popular articles published in Seminars in Thrombosis and Hemostasis. The awards are determined by the editor in chief on the basis of user statistics from Thieme eJournals from the preceding 2 years. The awards comprise two major cash prizes of US $1000 plus “open access” status for these articles thereafter. Young investigator awards: Best presentation or meeting abstract by a young investigator, as presented or delivered to an international meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. Up to six cash prizes of US $1000 in any year. Awardees are expected to prepare a review or other article related to the topic of their presentation for publication in Seminars in Thrombosis and Hemostasis.

Further details of the awards and the award winners are posted online (http://www.thieme.com/sth), and previous award winner announcements are also available in print.[4] [5] [6]

It is therefore with great pleasure that we would like to announce the latest winners of the Eberhard F. Mammen award for the most popular articles from Seminars in Thrombosis and Hemostasis for the period 2009 to 2010 inclusive, as well as the young investigator awards related to meetings held in 2010.

REFERENCES

  • 1 Favaloro E J. Editorial. Welcome to a special issue of Seminars in Thrombosis and Hemostasis—the closing issue for 2008.  Semin Thromb Hemost. 2008;  34 693-696
  • 2 Favaloro E J. A tribute to Eberhard F. Mammen, M.D. (1930–2008).  Semin Thromb Hemost. 2008;  34 (8) 703-707
  • 3 Favaloro E J. Editorial. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for 2009.  Semin Thromb Hemost. 2009;  35 1-2
  • 4 Favaloro E J. Editorial. Winners of the Inaugural Eberhard F. Mammen Award for Most Popular Article.  Semin Thromb Hemost. 2009;  35 587-590
  • 5 Favaloro E J. Editorial. 2009 Eberhard F. Mammen Young Investigator Award Winners.  Semin Thromb Hemost. 2010;  36 469-470
  • 6 Favaloro E J. Winners of the 2010 Eberhard F. Mammen award for most popular article during 2008–2009.  Semin Thromb Hemost. 2010;  36 (7) 685-692
  • 7 Sobieraj-Teague M, O'Donnell M, Eikelboom J. New anticoagulants for atrial fibrillation.  Semin Thromb Hemost. 2009;  35 (5) 515-524
  • 8 Favaloro E J, McDonald D, Lippi G. Laboratory investigation of thrombophilia: the good, the bad, and the ugly.  Semin Thromb Hemost. 2009;  35 (7) 695-710
  • 9 Mariani G, Bernardi F. Factor VII deficiency.  Semin Thromb Hemost. 2009;  35 (4) 400-406
  • 10 Jurk K, Kehrel B E. Platelets: physiology and biochemistry.  Semin Thromb Hemost. 2005;  31 (4) 381-392
  • 11 Viiala N O, Larsen S R, Rasko J E. Gene therapy for hemophilia: clinical trials and technical tribulations.  Semin Thromb Hemost. 2009;  35 (1) 81-92
  • 12 Asherson R A, Cervera R, Merrill J T, Erkan D. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.  Semin Thromb Hemost. 2008;  34 (3) 256-266
  • 13 Tripodi A, van den Besselaar A. Laboratory monitoring of anticoagulation: where do we stand?.  Semin Thromb Hemost. 2009;  35 (1) 34-41
  • 14 Zhou Z, Nguyen T C, Guchhait P, Dong J F. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.  Semin Thromb Hemost. 2010;  36 (1) 71-81
  • 15 Lippi G, Franchini M, Favaloro E J, Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the “French paradox.”  Semin Thromb Hemost. 2010;  36 (1) 59-70
  • 16 Lippi G, Favaloro E J, Franchini M, Guidi G C. Milestones and perspectives in coagulation and hemostasis.  Semin Thromb Hemost. 2009;  35 (1) 9-22
  • 17 Tincani A, Bazzani C, Zingarelli S, Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment.  Semin Thromb Hemost. 2008;  34 (3) 267-273
  • 18 Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency.  Semin Thromb Hemost. 2009;  35 (4) 426-438
  • 19 Harenberg J, Wehling M. Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.  Semin Thromb Hemost. 2008;  34 (1) 39-57
  • 20 Althaus K, Greinacher A. MYH9-related platelet disorders.  Semin Thromb Hemost. 2009;  35 (2) 189-203
  • 21 Fareed J, Hoppensteadt D A, Fareed D et al.. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.  Semin Thromb Hemost. 2008;  34 (1) 58-73
  • 22 Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases.  Semin Thromb Hemost. 2008;  34 (8) 772-778
  • 23 Pierangeli S S, Chen P P, Raschi E et al.. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.  Semin Thromb Hemost. 2008;  34 (3) 236-250
  • 24 McGlasson D L, Fritsma G A. Whole blood platelet aggregometry and platelet function testing.  Semin Thromb Hemost. 2009;  35 (2) 168-180
  • 25 de Moerloose P, Neerman-Arbez M. Congenital fibrinogen disorders.  Semin Thromb Hemost. 2009;  35 (4) 356-366
  • 26 Favaloro E J. Clinical utility of the PFA-100.  Semin Thromb Hemost. 2008;  34 (8) 709-733
  • 27 Wong R C, Favaloro E J. Clinical features, diagnosis, and management of the antiphospholipid syndrome.  Semin Thromb Hemost. 2008;  34 (3) 295-304
  • 28 Brenner B, Kuperman A A, Watzka M, Oldenburg J. Vitamin K–dependent coagulation factors deficiency.  Semin Thromb Hemost. 2009;  35 (4) 439-446
  • 29 Gisondi P, Girolomoni G. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.  Semin Thromb Hemost. 2009;  35 (3) 313-324
  • 30 Asselta R, Peyvandi F. Factor V deficiency.  Semin Thromb Hemost. 2009;  35 (4) 382-389
  • 31 Blum W, Porcu P. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.  Semin Thromb Hemost. 2007;  33 (4) 350-354
  • 32 Blann A, Shantsila E, Shantsila A. Microparticles and arterial disease.  Semin Thromb Hemost. 2009;  35 (5) 488-496
  • 33 Hunt B J. Pediatric antiphospholipid antibodies and antiphospholipid syndrome.  Semin Thromb Hemost. 2008;  34 (3) 274-281
  • 34 Harrison P, Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing.  Semin Thromb Hemost. 2009;  35 (2) 150-157
  • 35 Galli M. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.  Semin Thromb Hemost. 2008;  34 (4) 329-334
  • 36 Menegatti M, Peyvandi F. Factor X deficiency.  Semin Thromb Hemost. 2009;  35 (4) 407-415
  • 37 Enjeti A K, Lincz L F, Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology.  Semin Thromb Hemost. 2007;  33 (8) 771-779
  • 38 Harenberg J. New anticoagulants in atrial fibrillation.  Semin Thromb Hemost. 2009;  35 (6) 574-585
  • 39 Duga S, Salomon O. Factor XI deficiency.  Semin Thromb Hemost. 2009;  35 (4) 416-425 y
  • 40 Harenberg J. Development of new anticoagulants: present and future.  Semin Thromb Hemost. 2008;  34 (8) 779-793
  • 41 Hellgren M. Hemostasis during normal pregnancy and puerperium.  Semin Thromb Hemost. 2003;  29 (2) 125-130
  • 42 Levi M, Löwenberg E C. Thrombocytopenia in critically ill patients.  Semin Thromb Hemost. 2008;  34 (5) 417-424
  • 43 Meltzer M E, Doggen C J, de Groot P G, Rosendaal F R, Lisman T. The impact of the fibrinolytic system on the risk of venous and arterial thrombosis.  Semin Thromb Hemost. 2009;  35 (5) 468-477
  • 44 Peyvandi F, Palla R, Menegatti M, Mannucci P M. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management.  Semin Thromb Hemost. 2009;  35 (4) 349-355
  • 45 Zuern C S, Lindemann S, Gawaz M. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management.  Semin Thromb Hemost. 2009;  35 (3) 295-306
  • 46 Berntorp E, Salvagno G L. Standardization and clinical utility of thrombin-generation assays.  Semin Thromb Hemost. 2008;  34 (7) 670-682
  • 47 Baskurt O K, Meiselman H J. Blood rheology and hemodynamics.  Semin Thromb Hemost. 2003;  29 (5) 435-450
  • 48 Roberts H R, Hoffman M, Monroe D M. A cell-based model of thrombin generation.  Semin Thromb Hemost. 2006;  32 (Suppl 1) 32-38
  • 49 Bernardi E, Pesavento R, Prandoni P. Upper extremity deep venous thrombosis.  Semin Thromb Hemost. 2006;  32 (7) 729-736
  • 50 Prisco D, Grifoni E. The role of D-dimer testing in patients with suspected venous thromboembolism.  Semin Thromb Hemost. 2009;  35 (1) 50-59
  • 51 Prechel M, Walenga J M. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.  Semin Thromb Hemost. 2008;  34 (1) 86-96
  • 52 Kamphuisen P W, Rosendaal F R, Büller H R. Hemostatic abnormalities and arterial thrombosis.  Semin Thromb Hemost. 2009;  35 (5) 449-450
  • 53 Levi M, Schouten M, van der Poll T. Sepsis, coagulation, and antithrombin: old lessons and new insights.  Semin Thromb Hemost. 2008;  34 (8) 742-746
  • 54 Coppola A, Tufano A, Cerbone A M, Di Minno G. Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism.  Semin Thromb Hemost. 2009;  35 (7) 683-694
  • 55 Selleng K, Selleng S, Greinacher A. Heparin-induced thrombocytopenia in intensive care patients.  Semin Thromb Hemost. 2008;  34 (5) 425-438
  • 56 Mezzano D, Quiroga T, Pereira J. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays.  Semin Thromb Hemost. 2009;  35 (2) 242-254
  • 57 Hayward C P, Favaloro E J. Diagnostic evaluation of platelet disorders: the past, the present, and the future.  Semin Thromb Hemost. 2009;  35 (2) 127-130
  • 58 Peyvandi F, Favaloro E J. Rare bleeding disorders.  Semin Thromb Hemost. 2009;  35 (4) 345-347
  • 59 Wong R C, Favaloro E J. Antiphospholipid antibodies and the antiphospholipid syndrome. I: pathogenesis, clinical features, diagnosis, and management. Preface.  Semin Thromb Hemost. 2008;  34 (3) 213-218
  • 60 Lippi G, Favaloro E J, Franchini M. Laboratory diagnostics and therapy in thrombosis and hemostasis: from bedside to bench to bedside.  Semin Thromb Hemost. 2009;  35 (1) 3-8
  • 61 Franchini M, Lippi G, Favaloro E J. Coagulopathies and thrombosis: usual and unusual causes and associations, part I.  Semin Thromb Hemost. 2009;  35 (3) 257-259
  • 62 Kamphuisen P W, Rosendaal F R, Büller H R. Hemostatic abnormalities and arterial thrombosis.  Semin Thromb Hemost. 2009;  35 (5) 449-450
  • 63 Levi M. Hemostasis and thrombosis in critically ill patients.  Semin Thromb Hemost. 2008;  34 (5) 415-416
  • 64 Favaloro E J. Hot topics II: an editorial collection of current issues and controversies in thrombosis and hemostasis.  Semin Thromb Hemost. 2008;  34 (1) 3-6
  • 65 Favaloro E J. A tribute to Eberhard F. Mammen, M.D. (1930–2008).  Semin Thromb Hemost. 2008;  34 (8) 703-707

Emmanuel J FavaloroPh.D. F.F.Sc. (RCPA) 

Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital

SWAHS, Westmead, NSW, 2145, Australia

Email: emmanuel.favaloro@swahs.health.nsw.gov.au